Table 1.

General characteristics at admission.

Parameter	Value
Mean age (years) ±SD	66.8 ± 15.1
Mean BMI (kg/m2) ±SD	27.6 ± 5.3
Female sex (number of cases/percentage* [%])	84/48.3
Supplemental oxygen use (number of cases/percentage* [%])	100/57.8
Death (number of cases/percentage* [%])	30/17.2
NIV/CPAP/HFNO (number of cases/percentage* [%])	12/6.9
Mechanical ventilation (number of cases/percentage* [%])	3/1.7
Catecholamine infusion (number of cases/percentage* [%])	6/3.5
Hospital stay for at least 10 days (number of cases/percentage* [%])	87/50
Steroid use at any point of observation (number of cases/percentage* [%])	93/53.4
Chronic steroid use before hospital stay (number of cases/percentage* [%])	7/4.0
Abnormal TFTs at any point of observation (number of cases/percentage* [%])	140/80.5
History of hypothyroidism (number of cases/percentage* [%])	18/10.3
Levothyroxine supplementation prior to hospital stay (number of cases/percentage* [%])	15/8.6
History of hyperthyroidism (number of cases/percentage* [%])	2/1.1
Thyrostatic use prior to hospital stay (number of cases/percentage* [%])	2/1.1
History of arterial hypertension (number of cases/percentage* [%])	102/58.6
History of diabetes (number of cases/percentage* [%])	53/30.5
History of asthma and/or chronic obstructive pulmonary disease (number of cases/percentage* [%])	18/10.3
History of chronic kidney disease (number of cases/percentage* [%])	26/14.9
History of hemodialysis (number of cases/percentage* [%])	17/9.8
History of heart failure (number of cases/percentage* [%])	17/9.8
History of atrial fibrillation(number of cases/percentage* [%])	23/13.2
History of stroke (number of cases/percentage* [%])	11/6.3
History of pulmonary embolism (number of cases/percentage* [%])	3/1.7
History of active neoplasia (number of cases/percentage* [%])	14/8.1

All numbers were mathematically rounded to the first decimal place. *Related to patients with available information.